Federal prosecutors probing Glaxo diabetes pill

2010-10-21T15:00:48Z

Feds issue subpoena over Glaxo's diabetes pill Avandia, a month after FDA restricts its use

British drug maker GlaxoSmithKline reported Thursday that its controversial diabetes drug Avandia is under investigation by federal and state law enforcement officials in the U.S.

The announcement came less than a month after the

FDA to Greatly Restrict Use of Rosiglitazone

2010-11-02T13:57:07Z

...

Another Twist in the Chronicles of Avandia!

2010-11-02T14:14:45Z

...

FDA Panel Seems Skeptical Over Key Avandia Data

2010-09-10T20:11:39Z

...

Experts urge US to restrict drug Avandia

2010-07-14T22:15:38Z

A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale.

Most of the panel's members agreed that the drug increases the risk of heart problems, but only 12 of the 33-member expert panel voted to remove Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems.

The committee, convened at the request of the Food and Drug Administration, began its work on Tuesday as two US senators said Avandia manufacturer

FDA Panel Seems Skeptical Over Key Avandia Data

2010-09-10T13:39:14Z

...

Glaxo covered up diabetes drug's risks: US lawmakers

2010-07-13T13:15:37Z

British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday.

The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of expert...

Glaxo withheld info on diabetes drug's risks: US lawmakers

2010-07-13T11:16:38Z

UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday.

The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting...

Glaxo 'withheld info on diabetes drug's heart risks'

2010-07-13T08:16:32Z

British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday.

The allegation was made in the Wall S...

Glaxo withheld info on diabetes drug's heart risks: report

2010-07-13T08:15:52Z

The allegation was made in the Wall S...

Avandia Heart Risks Buried by Drug Company: Report

2010-09-10T17:37:01Z

...

U.S. meeting nears on risks of Glaxo diabetes drug

2010-07-13T01:30:15Z

WASHINGTON (Reuters) - A heated three-year safety debate about a GlaxoSmithKline Plc diabetes pill reaches a climax this week as opponents and backers face off at a U.S. meeting that will help decide the drug's fate.

A panel of scientific experts meets later Tuesday and again Wednesday to co...

FDA Reviewer Questions Results of Key Avandia Trial

2010-09-10T20:05:00Z

...

European agency to review safety of GSK's Avandia

2010-07-09T03:30:13Z

European Medicines Agency to review safety of GlaxoSmithKline's diabetes drug Avandia

The European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and dea...

EU agency probes safety of Glaxo's Avandia drug

2010-07-09T03:15:21Z

LONDON (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week.

The E...

Half doses of diabetes drugs can prevent disease

2010-06-02T15:45:41Z

WASHINGTON (Reuters) - Low doses of GlaxoSmithKline's diabetes drug Avandia combined with metformin can prevent diabetes without causing the most common side-effects, Canadian doctors reported on Wednesday.

Taking half a dose of Glaxo's combination pill reduced by two-thirds the risk that patients would...

U.S. group urges FDA to halt Glaxo's Avandia trial

2010-05-11T11:30:28Z

WASHINGTON (Reuters) - An major trial of Avandia puts patients at risk and should be stopped, a U.S. advocacy group said on Tuesday, calling on regulators to immediately halt the global study of the controversial GlaxoSmithKline Plc diabetes drug.

<...

FDA Mulling End to Avandia-Actos Trial on Safety Worries

2010-10-25T14:38:49Z

...

Glaxo defends handling of Avandia heart risks

2010-04-16T06:58:25Z

Glaxo fires back against Senate report, says it disclosed safety risks to FDA in 2005

GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record.

In a memo posted online, the British drugmaker takes aim at the highly critical

Diabetes Rivals Lick Chops Over Avandia Setback

2010-10-25T07:56:48Z

...

Doubts Build On Glaxo's Antiaging Drugs

2010-10-22T14:42:14Z

...

Avandia Attorney Says Study Based on 'Useless Trick Science'

2010-10-24T09:14:48Z

...

FDA wants closer scrutiny of new diabetes drugs

2010-11-02T12:42:12Z

...

2 Diabetes Drugs Double Fracture Risk in Women

2010-10-23T19:05:05Z

...

FDA panel urges more testing for diabetes drugs

2010-04-16T16:58:39Z

FDA panel wants longer studies to assure diabetes drugs don't raise heart attack risks

Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on Wednesday that all new diabetes drugs should underg...

has contested

2010-10-22T23:03:26Z

...

Takeda marketing campaign will tout safety of Actos just as Glaxo adds new warnings to Avandia

2010-09-10T11:22:44Z

Takeda Pharmaceuticals will roll out advertisements touting the safety of its diabetes drug Actos just two days after rival GlaxoSmithKline said it would beef up warnings about heart attack risks associated with its own diabetes pill, Avandia...

GlaxoSmithKline to close pharmaceutical plant in Puerto Rico over sagging sales

2010-09-10T06:11:26Z

Drug maker GlaxoSmithKline PLC said Wednesday it will close its troubled manufacturing plant in Puerto Rico because of declining sales of diabetes treatments and growing competition from generics.

The factory in Cidra, in central Puerto Rico, employs about 900 people. It opened in 1969 as the U.S. Caribbean ter...

FDA will ask medical experts whether Avandia should be pulled due to safety concerns

2010-09-09T11:06:38Z

The Food and Drug Administration will ask outside experts next week whether the diabetes drug Avandia should carry label warnings of heart attack risk.

The FDA scheduled a Monday meeting to ask drug safety and diabetes experts to review GlaxoSmithKline's blockbuster drug after a me...

Diabetes drugs Avandia, Actos to carry stronger warnings in US

2010-09-09T00:39:27Z

U.S. regulators will require tougher warnings about heart failure on the diabetes drugs Avandia and Actos, the head of the Food and Drug Administration said at a congressional hearing.

FDA Commissioner Andrew von Eschenbach revealed Wed...

Avandia to carry stronger warning label

2010-09-09T00:35:47Z

Diabetes Drugs Avandia, Actos to Carry Stronger Warnings; Lawmakers Rebuke FDA's Oversight

The Food and Drug Administration will require tougher warnings about heart failure on the diabetes drugs Avandia and Actos, FDA Commissioner Food and Drug Administration will require tougher warnings about heart failure on the diabetes drugs Avandia and Actos, FDA Commissioner Andrew von Eschenbach said at a congressional hearing Wednesday.

Von Eschenbach revealed that t...

Avandia concerns spark regulatory debate

2010-09-09T00:32:02Z

Democrats in Congress Use Avandia Controversy to Push for Tougher Restrictions on Drug Makers

WASHINGTON _ Safety concerns about a GlaxoSmithKline diabetes drug prompted some Democratic lawmakers on Wednesday to rebuke the Food and Drug Administration and call for...

Democrats in Congress use Avandia controversy to push for tougher restrictions on drug makers

2010-09-09T00:31:09Z

WASHINGTON _ Safety concerns about a GlaxoSmithKline diabetes drug prompted some Democratic lawmakers on Wednesday to rebuke the Food and Drug Administration and call for increased regulation of the pharmaceutical industry.

The controversy surrounding Glaxo's Avandia intensified wh...

Doctor says Avandia maker threatened to sue in 1999 when he raised safety questions

2010-09-09T00:30:36Z

The controversy surrounding GlaxoSmithKline's diabetes drug Avandia grew Wednesday as a medical expert told Congress that executives threatened to sue when he first raised questions in 1999 about the treatment's safety.

That testimony, coupled with a recent medical journal analysis highlighting the heart attack risks associated with Avandia, prompted some Democratic l...

Medical expert testifies that Glaxo threatened legal action when he raised safety Avandia

2010-09-09T00:26:10Z

The controversy surrounding GlaxoSmithKline's diabetes drug Avandia mounted Wednesday as a medical expert prepared to tell lawmakers the British drug maker threatened him with legal action when he first raised questions about the treatment's safety.

Dr. John Buse was contacted by Glaxo in 1999 after drawing attention t...

FDA declines to fast-track Glaxo vaccine

2010-09-08T23:22:54Z

FDA Denies Glaxo's Cancer Vaccine Fast Track Status; Company Defends Diabetes Drug

GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pre...

FDA denies Glaxo's cancer vaccine fast track status; company defends diabetes drug

2010-09-08T23:22:51Z

GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Diabetes Pill Raises Risk of Heart Attacks, Study Suggests, and Critics Say FDA Not Vigilant

A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug.

More than 6 million people worldwide have taken the drug, sold as

Study: Pill raises risk of heart attacks

2010-09-08T21:25:42Z

Study Finds Diabetes Pill Raises Risk of Heart Attacks; GlaxoSmithKline Acknowledges Danger

Mor...

Diabetes pill raises risk of heart attacks, study suggests

2010-09-08T21:22:34Z

A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the U.S. government failing to protect the public from an unsafe drug.

More than 6 million people worldwide have taken the drug, sold as Avandia and Avandamet,...

Discovery of heart risks with popular diabetes pill renews criticism of U.S. drug regulators

2010-09-08T21:22:32Z

First the painkiller Vioxx; now the diabetes drug Avandia. Another big drug safety issue has consumer groups, doctors and congressmen calling for an overhaul of the U.S. Food and Drug Administration.

On Monday, a medical journal published an analysis suggesting that Avandia raised the risk of heart attacks an...

Diabetes pill raises risk of heart attacks, study suggests, and critics say FDA not vigilant

2010-09-08T21:22:28Z

More than 6 million people worldwide have taken the drug, sold as Avandia and Avandamet, sinc...

Diabetes drug Avandia raises risk of heart attack, study suggests; FDA issues safety alert

2010-09-08T21:22:10Z

The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, a new scientific analysis revealed, and the U.S. government issued a safety alert Monday.

The Food and Drug Administration urged diabetics taking the pill to talk to their doctors, but stopped short of forcing a sharper warning label on the dru...

Diabetes drug Avandia raises the risk of heart attacks, study suggests

2010-09-08T21:13:38Z

The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, says a new scientific analysis published online Monday.

More than 6 million people worldwide have taken the drug sold by London-based GlaxoSmithKline PLC since it came on the market eight years ago....

BRITAIN GLAXOSMITHKLINE

2010-04-15T03:13:25Z

A sign for British pharmaceuticals firm GlaxoSmithKline is seen on its offices, in London, Monday, April 20, 2009. British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc. GlaxoSmithKline will also assu...

News on Glaxosmithkline Plc

Federal prosecutors probing Glaxo diabetes pill

FDA to Greatly Restrict Use of Rosiglitazone

Another Twist in the Chronicles of Avandia!

FDA Panel Seems Skeptical Over Key Avandia Data

Experts urge US to restrict drug Avandia

FDA Panel Seems Skeptical Over Key Avandia Data

Glaxo covered up diabetes drug's risks: US lawmakers

Glaxo withheld info on diabetes drug's risks: US lawmakers

Glaxo 'withheld info on diabetes drug's heart risks'

Glaxo withheld info on diabetes drug's heart risks: report

Avandia Heart Risks Buried by Drug Company: Report

U.S. meeting nears on risks of Glaxo diabetes drug

FDA Reviewer Questions Results of Key Avandia Trial

European agency to review safety of GSK's Avandia

EU agency probes safety of Glaxo's Avandia drug

Half doses of diabetes drugs can prevent disease

U.S. group urges FDA to halt Glaxo's Avandia trial

FDA Mulling End to Avandia-Actos Trial on Safety Worries

Glaxo defends handling of Avandia heart risks

Diabetes Rivals Lick Chops Over Avandia Setback

Doubts Build On Glaxo's Antiaging Drugs

Avandia Attorney Says Study Based on 'Useless Trick Science'

FDA wants closer scrutiny of new diabetes drugs

2 Diabetes Drugs Double Fracture Risk in Women

FDA panel urges more testing for diabetes drugs

has contested

Takeda marketing campaign will tout safety of Actos just as Glaxo adds new warnings to Avandia

GlaxoSmithKline to close pharmaceutical plant in Puerto Rico over sagging sales

FDA will ask medical experts whether Avandia should be pulled due to safety concerns

Diabetes drugs Avandia, Actos to carry stronger warnings in US

Avandia to carry stronger warning label

Avandia concerns spark regulatory debate

Democrats in Congress use Avandia controversy to push for tougher restrictions on drug makers

Doctor says Avandia maker threatened to sue in 1999 when he raised safety questions

Medical expert testifies that Glaxo threatened legal action when he raised safety Avandia

FDA declines to fast-track Glaxo vaccine

FDA denies Glaxo's cancer vaccine fast track status; company defends diabetes drug

Study: Pill raises risk of heart attacks

Diabetes pill raises risk of heart attacks, study suggests

Discovery of heart risks with popular diabetes pill renews criticism of U.S. drug regulators

Diabetes pill raises risk of heart attacks, study suggests, and critics say FDA not vigilant

Diabetes drug Avandia raises risk of heart attack, study suggests; FDA issues safety alert

Diabetes drug Avandia raises the risk of heart attacks, study suggests

BRITAIN GLAXOSMITHKLINE